Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7318-7327

  Petti, Lisa M ^a   Reddy, Venkat ^b   Smith, Steven O ^c   Dimaio, Daniel ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; BINDING SITE; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION;

EID: 0030768754     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7318-7327.1997     Document Type: Article

References (47)

1. Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649-657.
2. Bargmann, C. I., and R. A. Weinberg. 1988. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl. Acad. Sci. USA 85:5394-5398.
3. Burkhardt, A., D. DiMaio, and R. Schlegel. 1987. Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein. EMBO J. 6:2381-2385.
4. Burkhardt, A., M. Willingham, C. Gay, K.-T. Jeang, and R. Schlegel. 1989. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology 170:334-339.
5. Claesson-Welsh, L., A. Eriksson, A. Morén, L. Severinsson, B. Ek, A. Östman, C. Betsholtz, and C. H. Heldin. 1988. cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol. Cell. Biol. 8:3476-3486.
6. Claesson-Welch, L., A. Eriksson, B. Westermark, and C. H. Heldin. 1989. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural simularity to the B-type PDGF receptor. Proc. Natl. Acad. Sci. USA 86:4917-4921.
7. Cohen, B. D., D. J. Goldstein, L. Rutledge, W. C. Vass, D. R. Lowy, R. Schlegel, and J. Schiller. 1993. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J. Virol. 67:5303-5311.
8. Cohen, B. D., D. R. Lowy, and J. Schiller. 1993. The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an α-adaptin-like molecule: a possible link between growth factor receptors and viral transformation. Mol. Cell. Biol. 13:6462-6468.
9. Cosson, P., S. P. Lankford, J. S. Bonifacino, and R. D. Klausner. 1991. Membrane protein association by potential intramembrane charge pairs. Nature 351:414-416.
10. Deng, W. P., and J. A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88.
11. DiMaio, D., L. Petti, and E.-S. Hwang. 1994. The E5 transforming proteins of the papillomaviruses. Semin. Virol. 5:369-379.
12. Drummond-Barbosa, D., R. R. Vaillancourt, A. Kazlauskas, and D. DiMaio. 1995. Ligand-independent activation of the platelet-derived growth factor β receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. Cell. Biol. 5:2570-2581.
13. Goldstein, D. J., T. Andresson, J. J. Sparkowski, and R. Schlegel. 1992. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J. 11:4851-4859.
14. +-ATPase. Nature 352:347-349.
15. Goldstein, D. J., W. Li, L.-M. Wang, M. A. Heidaran, S. A. Aaronson, R. Shinn, R. Schlegel, and J. H. Pierce. 1994. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the β-type receptor for platelet-derived growth factor but not other tyrosine kinase-conlaining receptors to induce cellular transformation. J. Virol. 68:4432-4441.
16. Heldin, C.-H. 1996. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
17. Henningson, C. 1996. Characterization of the interactions between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor β receptor. M.D. thesis. Yale University, New Haven, Conn.
18. Hoatlin, M. E., S. L. Kozak, F. Lilly, A. Chakraborti, C. A. Kozak, and D. Kabat. 1990. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-22 resistence gene. Proc. Natl. Acad. Sci. USA 87:9985-9989.
19. Horwitz, B. H., D. L. Weinstat, and D. DiMaio. 1989. Transforming activity of a sixteen-amino-acid segment of the bovine papillomavirus E5 protein linked to random sequences of hydrophobic amino acids. J. Virol. 63:4515-4519.
20. Horwitz, B. H., A. L. Burkhardt, R. Schlegel, and D. DiMaio. 1988. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids. Mol. Cell. Biol. 8:4071-4078.
21. 20a.Klein, D., G. W. Polack, and D. DiMaio. Unpublished data.
22. Kulke, R., B. H. Horwitz, T. Zibello, and D. DiMaio. 1992. The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many random sequences containing a glutamine. J. Virol. 66:505-511.
23. Lemmon, M. A., and D. M. Engelman. 1994. Specificity and promiscuity in membrane helix interactions. Q. Rev. Biophys. 27:157-218.
24. Lemmon, M. A., J. M. Flanagan, J. F. Hunt, B. D. Adair, B.-J. Bormann, C. E. Dempsey, and D. M. Engelman. 1992. Glycophorin A dimerization is driven by specific interactions between transmembrane α-helices. J. Biol. Chem. 267:7683-7689.
25. Leptak, C., S. Ramon y Cajal, R. Kulke, D. R. Riese, B. H. Horwitz, G. P. Dotto, and D. DiMaio. 1991. Tumorigenic transformation of mouse keratinocytes by the E5 genes of human papillomavirus type 16 and bovine papillomavirus type 1. J. Virol. 65:7078-7083. (Erratum, 66:1833, 1992.)
26. Li, J. P., A. D. D'Andrea, H. F. Lodish, and D. Baltimore. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762-764.
27. Manolios, N., J. S. Bonifacino, and R. D. Klausner. 1990. Transmembrane helical interactions and the assembly of the T cell receptor complex. Science 249:274-276.
28. Martin, P., W. Vass, J. T. Schiller, D. Lowy, and T. J. Velu. 1989. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell 59:21-32.
29. Matsui, T., M. Heidaran, T. Miki, N. Popesui, W. LaRochelle, M. Kraus, J. Pierce, and S. Aaronson. 1989. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243:800-804.
30. Meyer, A. N., Y.-F. Xu, M. K. Webster, A. S. Smith, and D. J. Donoghue. 1994. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein. Proc. Natl. Acad. Sci. USA 91:4634-4638.
31. Nilson, L. A., and D. DiMaio. 1993. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol. Cell. Biol. 13:4137-4143.
32. Nilson, L. A., R. L. Gottlieb, G. W. Polack, and D. DiMaio. 1995. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous β receptor for platelet-derived growth factor in mouse C127 cells. J. Virol. 69:5869-5874.
33. Palacios, R., and M. Steinmetz. 1985. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727-734.
34. Petti, L., and D. DiMaio. 1997. Unpublished data.
35. Petti, L., and D. DiMaio. 1994. Specific interaction between the bovine papillomavirus E5 transforming protein and the β receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J. Virol. 68:3582-3592.
36. Petti, L., and D. DiMaio. 1992. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. Proc. Natl. Acad. Sci. USA 89:6736-6740.
37. Petti, L., P. Irusta, V. Reddy, and D. DiMaio. Unpublished data.
38. Petti, L., L. A. Nilson, and D. DiMaio. 1991. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10:845-855.
39. Schlegel, R., M. Wade-Glass, M. S. Rabson, and Y.-C. Yang. 1986. The E5 transforming gene of bovine papillomavirus encodes a small hydrophobic protein. Science 233:464-467.
40. Settleman, J., A. Fazeli, J. Malicki, B. H. Horwitz, and D. DiMaio. 1989. Genetic evidence that acute morphologic transformation, induction of cellular DNA synthesis, and focus formation are mediated by a single activity of the bovine papillomavirus E5 protein. Mol. Cell. Biol. 9:5563-5572.
41. Smith, S. O., C. S. Smith, and B. J. Bormann. 1996. Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor. Nat. Struct. Biol. 3:252-258.
42. Sparkowski, J., M. Mense, J. Anders, and R. Schlegel. 1996. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J. Virol. 70:2420-2430.
43. Sparkowski, J., J. Anders, and R. Schlegel. 1994. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J. Virol. 68:6120-6123.
44. Staebler, A., J. H. Pierce, S. Brazinski, M. A. Heidaran, W. Li, R. Schlegel, and D. J. Goldstein. 1995. Mutational analysis of the β-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. J. Virol. 69:6507-6517.
45. Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339:230-231.
46. Yarden, Y., J. A. Escobedo, W.-J. Kuang, T. L. Yang-Feng, T. O. Daniels, P. P. Tremble, E. Y. Cheng, M. E. Ando, R. N. Harkins, U. Francke, V. A. Fried, and L. T. Williams. 1986. Structure of the receptor for platelet-derived growth factor helps to define a family of closely related growth factor receptors. Nature 325:226-232.
47. Zon, L. I., J.-F. Moreau, J.-W. Koo, B. Mathey-Prevot, and A. D. D'Andrea. 1992. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Mol. Cell. Biol. 12:2949-2957.